The Valley Desk

NCT07536269 · Interventional trial

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

Overall registry status Recruiting

Phase 2

Conditions Congenital Adrenal Hyperplasia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov